Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Structure Therapeutics Inc. | 3,260,495 | reported | 07 Feb 2023 | tx 3+917,245−642,245 |
| Schrodinger, Inc. | 330,824 | reported | 05 Mar 2026 | tx 29+2,110,035−292,993 |
| Vir Biotechnology, Inc. | 16,000 | reported | 27 May 2026 | tx 7+96,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Vir Biotechnology, Inc. | 8,000 | 0.00 USD | |
| 27 May 2026 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 05 Mar 2026 | SALE | Schrodinger, Inc. | 3,661 | 12.91 USD | |
| 02 Mar 2026 | GRANT_AWARD | Schrodinger, Inc. | 56,250 | 0.00 USD | |
| 02 Mar 2026 | SALE | Schrodinger, Inc. | 5,560 | 11.90 USD | |
| 02 Mar 2026 | GRANT_AWARD | Schrodinger, Inc. | 48,259 | 0.00 USD | |
| 02 Mar 2026 | GRANT_AWARD | Schrodinger, Inc. | 13,604 | 0.00 USD | |
| 02 Mar 2026 | GRANT_AWARD | Schrodinger, Inc. | 112,500 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | Vir Biotechnology, Inc. | 8,000 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Schrodinger, Inc. | 37,500 | 0.00 USD | |
| 03 Mar 2025 | GRANT_AWARD | Schrodinger, Inc. | 60,000 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Schrodinger, Inc. | 90,000 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | |
| 29 May 2024 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 04 Mar 2024 | GRANT_AWARD | Schrodinger, Inc. | 126,000 | 0.00 USD | deriv |
| 04 Mar 2024 | GRANT_AWARD | Schrodinger, Inc. | 87,271 | 0.00 USD | deriv |
| 09 Feb 2023 | GRANT_AWARD | Schrodinger, Inc. | 84,960 | 0.00 USD | deriv |
| 09 Feb 2023 | GRANT_AWARD | Schrodinger, Inc. | 65,525 | 0.00 USD | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 642,245 | — | |
| 07 Feb 2023 | PURCHASE | Structure Therapeutics Inc. | 275,000 | 15.00 USD | deriv |
| 07 Feb 2023 | CONVERSION | Structure Therapeutics Inc. | 642,245 | — | deriv |
| 04 Jan 2023 | SALE | Schrodinger, Inc. | 66,886 | 18.28 USD | |
| 04 Jan 2023 | EXERCISE | Schrodinger, Inc. | 66,886 | 1.20 USD |